Llwytho...

Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study

Tenapanor (RDX5791/AZD1722) is a minimally systemic small‐molecule inhibitor of the sodium/hydrogen exchanger NHE3. Tenapanor acts in the gut to reduce absorption of sodium and phosphate. This phase 1 open‐label, 3‐way crossover study (NCT02226783) evaluated the effect of food on the pharmacodynamic...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Pharmacol Drug Dev
Prif Awduron: Johansson, Susanne A., Knutsson, Mikael, Leonsson‐Zachrisson, Maria, Rosenbaum, David P.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2017
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599956/
https://ncbi.nlm.nih.gov/pubmed/28339149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.341
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!